Smartnuclide Biopharma
Clinical trials sponsored by Smartnuclide Biopharma, explained in plain language.
-
New imaging agent lights up colorectal tumors in early trial
Diagnosis CompletedThis study tested a new radioactive imaging agent called 68Ga-NODAGA-SNA009 in 12 people with colorectal cancer. The goal was to see if it is safe and how it spreads through the body and tumors. Researchers measured radiation doses and checked if the agent can help spot cancer ce…
Phase: EARLY_PHASE1 • Sponsor: SmartNuclide Biopharma • Aim: Diagnosis
Last updated May 22, 2026 13:50 UTC
-
New PET tracer shows promise for spotting tumors
Diagnosis CompletedThis early-phase study tested a new imaging agent called 68Ga-NOTA-SNA002 in 17 adults with solid tumors. The agent was injected into the bloodstream to see how safe it is and how it spreads in the body using PET scans. The goal was to understand its safety and imaging properties…
Phase: PHASE1 • Sponsor: SmartNuclide Biopharma • Aim: Diagnosis
Last updated May 20, 2026 11:57 UTC